Key Points Novo Nordisk has a significant presence in the U.S. manufacturing sector and is expanding its facility. The administration won't impose tariffs until negotiations are closed. The drugmaker is awaiting approval to market an oral medication for weight loss. 10 stocks we like better than Novo Nordisk › Shares in Novo Nordisk (NYSE: NVO) were up 6% by 11:30 a.m. on Wednesday. The move comes after Pfizer's agreement with the Trump administration raised hopes that other pharmaceutical compan ...